Yong‐Oon Ahn
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
- T-cell and B-cell Immunology
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 27
- Immune Cell Function and Interaction 20
- T-cell and B-cell Immunology 6
- IL-33, ST2, and ILC Pathways 4
- Reproductive System and Pregnancy 3
- Immune cells in cancer 3
- Oncology 14
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Dae Seog Heo (25 shared papers)Tae Min Kim (19 shared papers)Bhumsuk Keam (15 shared papers)Dong‐Wan Kim (11 shared papers)Se‐Hoon Lee (9 shared papers)Michael R. Verneris (8 shared papers)Jeffrey S. Miller (6 shared papers)Yoon Kyung Jeon (3 shared papers)
- Journals
- Cancer Research (5 papers)Blood (4 papers)The Journal of Immunology (3 papers)Cancer Research and Treatment (2 papers)Cytotherapy (2 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Yong‐Oon Ahn
46 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 77
- Immunology 620
- Oncology 579
- Genetics 105
- Hematology 108
- Pulmonary and Respiratory Medicine 255
Countries citing papers authored by Yong‐Oon Ahn
This map shows the geographic impact of Yong‐Oon Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Oon Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Oon Ahn more than expected).
Fields of papers citing papers by Yong‐Oon Ahn
This network shows the impact of papers produced by Yong‐Oon Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Oon Ahn. The network helps show where Yong‐Oon Ahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Yong‐Oon Ahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 192 | |
| 2 | 2016 | 130 | |
| 3 | 2009 | 95 | |
| 4 | 2017 | 75 | |
| 5 | 2011 | 62 | |
| 6 | 2006 | 56 | |
| 7 | 2018 | 54 | |
| 8 | 2013 | 53 | |
| 9 | 2013 | 50 | |
| 10 | 2018 | 50 | |
| 11 | 2014 | 49 | |
| 12 | 2011 | 48 | |
| 13 | 2017 | 46 | |
| 14 | In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer. | 2015 | 45 |
| 15 | 2015 | 36 | |
| 16 | 2013 | 28 | |
| 17 | 2013 | 27 | |
| 18 | 2011 | 25 | |
| 19 | 2011 | 24 | |
| 20 | 2016 | 23 |
About Yong‐Oon Ahn
Yong‐Oon Ahn is a scholar working on Immunology, Oncology, Hematology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (5 papers), IL-33, ST2, and ILC Pathways (4 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Reproductive System and Pregnancy (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Immunology (620 citations), Oncology (579 citations), Genetics (105 citations), Hematology (108 citations) and Pulmonary and Respiratory Medicine (255 citations). Yong‐Oon Ahn has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Dae Seog Heo, Tae Min Kim, Bhumsuk Keam, Dong‐Wan Kim, Se‐Hoon Lee, Michael R. Verneris, Jeffrey S. Miller, Yoon Kyung Jeon, Soyeon Kim and Bruce R. Blazar. Their work appears in journals such as Cancer Research, Blood, The Journal of Immunology, Cancer Research and Treatment and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.